Established five years ago in Colorado, 1906 has recently expanded to Illinois, Oklahoma and now Massachusetts. AmeriCann's MCC provided 1906 with a product manufacturing solution with scale to participate in the rapidly expanding Massachusetts market.
1906's signature line of fast-acting, swallowable pills (known as drops) range from 2.5-5 mg THC and 2.5-25 mg CBD per dose, carry no taste or aroma, have zero calories, and are gluten- and allergen-free. Available in six formulations, Drops address everyday wellness needs: better sleep, reduced anxiety, sustained focus, more energy, brighter mood and increased libido.
"AmeriCann identified the need for quality low-dose products in Massachusetts," said AmeriCann president Tim Keogh. "We selected 1906 as the ideal partner to meet this important consumer category. 1906 Drops appeal to a rapidly growing segment of cannabis consumers in an attractive, convenient form."
The Massachusetts Cannabis Center is located on a 52-acre parcel in Southeastern Massachusetts. The MCC project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure. 1906 Drops are produced and distributed in Building 1 of the MCC. AmeriCann receives 15 percent of all gross sales produced from Building 1, including wholesale sales of 1906 products.
"The Massachusetts Cannabis Center provided an ideal launching pad for 1906 in the Northeast," said Peter Barsoom, 1906 co-founder and CEO. "Having quality cannabis cultivation and manufacturing together on one campus is a great combination for producing a quality product at scale."